
<html>

<head>

<meta name="GENERATOR" content="Microsoft Internet Assistant for PowerPoint 97">
<title>Diabetic Neuropathy</title>
</head>

<BODY     >
<CENTER>
<h1>Diabetic Neuropathy</h1>
<h4>5/28/02</h4>
<br><h2> <A HREF="sld001.htm">Click here to start</A>
 </h2><br>  
</center>
<center>
 <table width=90%>
  <tr>
   <td valign=top align=left width=50%>
      <h3><u>Table of Contents</u></h3>
            <P ALIGN=LEFT><A HREF="sld001.htm">PPT Slide</A></P>
        <P ALIGN=LEFT><A HREF="sld002.htm">PPT Slide</A></P>
        <P ALIGN=LEFT><A HREF="sld003.htm">Diabetic Neuropathy</A></P>
        <P ALIGN=LEFT><A HREF="sld004.htm">Myelinated Neuron</A></P>
        <P ALIGN=LEFT><A HREF="sld005.htm">PNS Anatomy</A></P>
        <P ALIGN=LEFT><A HREF="sld006.htm">Diabetic Peripheral Nerve Damage</A></P>
        <P ALIGN=LEFT><A HREF="sld007.htm">Neuropathic Symptoms and Signs</A></P>
        <P ALIGN=LEFT><A HREF="sld008.htm">PNS Anatomy</A></P>
        <P ALIGN=LEFT><A HREF="sld009.htm">Neuropathic Symptoms</A></P>
        <P ALIGN=LEFT><A HREF="sld010.htm">Neuropathic Signs</A></P>
        <P ALIGN=LEFT><A HREF="sld011.htm"> Diabetic Peripheral Neuropathy</A></P>
        <P ALIGN=LEFT><A HREF="sld012.htm">San Antonio Consensus Statement</A></P>
        <P ALIGN=LEFT><A HREF="sld013.htm">DCCT Design</A></P>
        <P ALIGN=LEFT><A HREF="sld014.htm">DCCT Neurological Outcome</A></P>
        <P ALIGN=LEFT><A HREF="sld015.htm">PPT Slide</A></P>
        <P ALIGN=LEFT><A HREF="sld016.htm">Aldose Reductase and Alcar Trials</A></P>
        <P ALIGN=LEFT><A HREF="sld017.htm">Sural Nerve Biopsies in Man</A></P>
        <P ALIGN=LEFT><A HREF="sld018.htm">Axon Counts in Human Sural Nerves</A></P>
        <P ALIGN=LEFT><A HREF="sld019.htm">Axon Loss inDiabetic Neuropathy</A></P>
        <P ALIGN=LEFT><A HREF="sld020.htm">Aldose Reductase:  Zenerstat</A></P>
        <P ALIGN=LEFT><A HREF="sld021.htm">Change in NCS: Sural and Composite with Zenarestat</A></P>
        <P ALIGN=LEFT><A HREF="sld022.htm">Change in Nerve fiber Density with Zenarestat</A></P>
        <P ALIGN=LEFT><A HREF="sld023.htm">Zenarestat Increases the MNFD for Small Myelinated Fibers</A></P>
        <P ALIGN=LEFT><A HREF="sld024.htm">Aldose Reductase:  ZenerstatPhase III Trial</A></P>
        <P ALIGN=LEFT><A HREF="sld025.htm">Nerve Growth Factor</A></P>
        <P ALIGN=LEFT><A HREF="sld026.htm">PPT Slide</A></P>
        <P ALIGN=LEFT><A HREF="sld027.htm">Change in the Lower Limb NIS With NGF</A></P>
        <P ALIGN=LEFT><A HREF="sld028.htm">Changes in CDT and HPT in the hNGF-Diabetic Neuropathy Study</A></P>
        <P ALIGN=LEFT><A HREF="sld029.htm">Nerve Growth FactorPhase III  </A></P>
        <P ALIGN=LEFT><A HREF="sld030.htm">Measures in Current and Proposed Trials</A></P>
        <P ALIGN=LEFT><A HREF="sld031.htm">Measures in Current and Proposed Trials</A></P>
        <P ALIGN=LEFT><A HREF="sld032.htm">Clinical Endpoints</A></P>
        <P ALIGN=LEFT><A HREF="sld033.htm">Entry Criteria</A></P>

   </td>
   <td valign=top width=50%>
	 <strong>Author: </strong>Internal Medicine 
    
	
	
	
	
	
   </td>
  </tr>
 </table>
</center>

</body>

</html>
